Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates
Sialidases or neuraminidases play important roles in various physiological and pathological processes by cleaving terminal sialic acids (Sias) (desialylation) from the glycans of both glycoproteins and glycolipids. To understand the biological significance of desialylation by sialidases, it is important to investigate enzyme specificity with native substrate in biological membrane of cells. Herein, we report a membrane-mimicking system with liposome ganglioside conjugates containing different lipids for evaluating substrate specificity of sialidase and the lipid effect on the enzyme activity. Briefly, liposomes of phosphatidylcholine (PC) and cholesterol with ganglioside (GM3 or GM1) along with different percentage of phosphatidylserine (PS) or phosphatidylethanolamine (PE) were prepared and characterized. Their desialylation profiles with Arthrobacter ureafaciens (bacterial) sialidase and H1N1 (influenza viral) sialidase were quantified by HPLC method. A diversity of substrate preference was found for both bacterial and viral sialidase to the liposome ganglioside conjugate platform. The apparent Km and Vmax were dependent on the type of lipid. These results indicate that the intrinsic characteristics of the membrane-like system affect the sialidase specificity and activity. This biomimetic substrate provides a better tool for unravelling the substrate specificity and the biological function of sialidases and for screening of functional sialidase inhibitors as well.
KeywordsDesialylation Ganglioside Lipid Liposome Sialidase
This work was supported by Faculty Research Fund from the Center for Gene Regulation in Health and Disease (GRHD) and Faculty Research Development (FRD) Fund at Cleveland State University.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 11.Szymanski, C.M., Schnaar, R.L., Aebi, M. Bacterial and viral infections. In: Varki, A., Cummings, R.D., Esko, J.D., et al., editors. Essentials of Glycobiology [Internet]. 3rd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2015-2017. Chapter 42 (2017).Google Scholar
- 26.Pan, X, De Aragão, CBP, Velasco-Martin, JP, Priestman, DA, Wu, HY, Takahashi, K, Yamaguchi, K., Sturiale, L., Garozzo, D., Platt, F.M., Lamarche-Vane, N., Morales, C.R., Miyagi, T., Pshezhetsky, A.V.: Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides. FASEB J.31, 3467-3483(2017).PubMedCrossRefGoogle Scholar
- 29.Tringali, C., Papini, N., Fusi, P., Croci, G., Borsani, G., Preti, A., Tortora, P., Tettamanti, G., Venerando, B., Monti, E.: Properties of recombinant human cytosolic sialidase HsNEU2. The enzyme hydrolyzes monomerically dispersed GM1 ganglioside molecules. J. Biol. Chem.279, 3169-79 (2004).PubMedCrossRefGoogle Scholar
- 36.Saito, M., Sugano, K., Nagai, Y.: Action of Arthrobacter ureafaciens sialidase on sialoglycolipid substrates. Mode of action and highly specific recognition of the oligosaccharide moiety of ganglioside GM1. J. Biol. Chem.254, 7845-7854 (1979).Google Scholar
- 37.Hitika, T., Aritomi, K., Tanaka, N., Toyoda, H., Suzuki, A., Toida, T., Abe, T., Yanagawa, Y., Ishizuka, I.: Determination of N-acetyl- and N-glycolylneuraminic acids in gangliosides by combination of neuraminidase hydrolysis and fluorometric high-performance liquid chromatography using a GM3 derivative as an internal standard. Anal. Biochem.281, 193–201 (2000)CrossRefGoogle Scholar